Original Research

Accepted on 08 May 2024

Immune Cell Infiltration and Prognostic Index in Cervical Cancer: Insights from Metabolism-Related Differential Genes

in Cancer Immunity and Immunotherapy

Boyi Ma
Chenlu Ren
Yadong Yin
Shuhua Zhao
Jia Li
Hong Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1411132

Review

Accepted on 08 May 2024

A new perspective on hematological malignancies: m6A modification in immune microenvironment

in Cancer Immunity and Immunotherapy

Shiyu Yang
Liping Xu
Haihui Zhuang
Fenglin Li
Ying Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374390

Original Research

Accepted on 08 May 2024

CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma

in Cancer Immunity and Immunotherapy

Jinchao Wang
kai wang
Xiaoru Li
Kaiji LI
Gao Yalong
Jianye Xu
Ruilong Peng
Xu Zhang
Chen Shang Xu
Shu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1361351

Systematic Review

Accepted on 08 May 2024

Machine learning in the prediction of immunotherapy response and prognosis of melanoma: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Juan Li
Kena Dan
Jun Ai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1281940

115 views

Original Research

Accepted on 08 May 2024

Interpretable machine learning for predicting the response duration to Sintilimab plus chemotherapy in patients with advanced gastric or gastroesophageal junction cancer

in Cancer Immunity and Immunotherapy

Danqi Wang
Wenhuan Xu
Xiaowei Cheng
Lei Hua
Xiaosong Ge
Li Liu
Xiang Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407632

Mini Review

Published on 08 May 2024

A review of lactate-lactylation in malignancy: its potential in immunotherapy

in Cancer Immunity and Immunotherapy

Jinhui Zha
Junan Zhang
Jingfen Lu
Guangcheng Zhang
Mengzhan Hua
Weiming Guo
Jing Yang
Gang Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384948

154 views

Original Research

Published on 08 May 2024

Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer

in Cancer Immunity and Immunotherapy

Chuanchang Li
Junyong Weng
Le Yang
Hangjun Gong
Zhaolong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1378305

117 views

Mini Review

Published on 08 May 2024

Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers

in Cancer Immunity and Immunotherapy

Ariel Perez
Tiba Al Sagheer
George R. Nahas
Yuliya P. L. Linhares

Frontiers in Immunology

doi 10.3389/fimmu.2024.1412002

180 views

Review

Published on 08 May 2024

Neutrophils in glioma microenvironment: from immune function to immunotherapy

in Cancer Immunity and Immunotherapy

Chao Sun
Siwen Wang
Zhen Ma
Jinghuan Zhou
Zilin Ding
Guoqiang Yuan
Yawen Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393173

116 views

Review

Published on 08 May 2024

Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy

in Cancer Immunity and Immunotherapy

Kun Li
Hongyan Nie
Runming Jin
Xiaoyan Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397005

Original Research

Published on 08 May 2024

Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Guozhen Yang
Haodong Yue
Xiaomin Zhang
Chufeng Zeng
Linyu Tan
Xu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1336798

159 views

Case Report

Published on 08 May 2024

Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy

in Cancer Immunity and Immunotherapy

Carlos Torrado
Mehmet A. Baysal
Abhijit Chakraborty
Becky L. Norris
Fareed Khawaja
Apostolia M. Tsimberidou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366271

148 views

Hypothesis and Theory

Published on 08 May 2024

Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments

in Cancer Immunity and Immunotherapy

Paolo Castorina
Filippo Castiglione
Gianluca Ferini
Stefano Forte
Emanuele Martorana
Dario Giuffrida

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373738

Original Research

Published on 08 May 2024

IL-38 promotes the development of prostate cancer

in Cancer Immunity and Immunotherapy

Huiyan Wu
Jing Yang
Liuhong Yuan
Zhenyu Tan
Xiuqin Zhang
Brett D. Hambly
Shisan Bao
Kun Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384416

Original Research

Published on 08 May 2024

Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1

in Cancer Immunity and Immunotherapy

Abd Aziz Ibrahim
Taku Fujimura
Tomoko Uno
Tomoya Terada
Ken-ichi Hirano
Hiroyuki Hosokawa
Akio Ohta
Toshio Miyata
Kiyoshi Ando
Takashi Yahata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365894

130 views

Original Research

Accepted on 07 May 2024

Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Tinotenda Blessing Madzikatire
Heng Shan
Hongyi Gu
Yunfeng Shan
Enhua Lin
Joshua Banda
Asta Debora
Brandon Anotida Madziva
Mutale Jaeste Bowa
Munyaradzi Godfrey Mudhuri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390887

Navigation group

Articles

Immune Cell Infiltration and Prognostic Index in Cervical Cancer: Insights from Metabolism-Related Differential Genes

A new perspective on hematological malignancies: m6A modification in immune microenvironment

CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma

Machine learning in the prediction of immunotherapy response and prognosis of melanoma: A systematic review and meta-analysis

Interpretable machine learning for predicting the response duration to Sintilimab plus chemotherapy in patients with advanced gastric or gastroesophageal junction cancer

A review of lactate-lactylation in malignancy: its potential in immunotherapy

Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer

Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers

Neutrophils in glioma microenvironment: from immune function to immunotherapy

Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy

Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma

Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy

Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments

IL-38 promotes the development of prostate cancer

Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1

Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma